Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-13-005265
Filing Date
2013-05-03
Accepted
2013-05-03 14:01:23
Documents
1
Period of Report
2013-05-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rdgdoc.html 4  
1 PRIMARY DOCUMENT rdgdoc.xml 4 4914
  Complete submission text file 0001437749-13-005265.txt   6255
Mailing Address 81 FULTON STREET BOONTON NJ 07005
Business Address 81 FULTON STREET BOONTON NJ 07005 973-265-1100
UNIGENE LABORATORIES INC (Issuer) CIK: 0000352747 (see all company filings)

EIN.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O UNIGENE LABORATORIES, INC. 81 FULTON ST. BOORTON NJ 07005
Business Address
Tune Joel A. (Reporting) CIK: 0001501799 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16005 | Film No.: 13811839